SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001029869-97-000240
Filing Date
1997-02-14
Accepted
1997-02-14 00:00:00
Documents
1
Group Members
ALAN G. WALTONCORNELIUS T. RYANKENNETH W. RINDOXFORD PARTNERS III LPOXFORD PARTNERS III-A, LIMITED PARTNERSHIPOXFORD VENTURE FUND III ADJUNCT, LPOXFORD VENTURE FUND III, LIMITED PARTNERSHIPSTEVEN A. BIRNBAUM
SROs
NONE

Document Format Files

Seq Description Document Type Size
1 SC 13G/A 38494
  Complete submission text file 0001029869-97-000240.txt   40680
Mailing Address
Business Address 215 COLLEGE RD PARAMUS NJ 07652 2012611331
SYNAPTIC PHARMACEUTICAL CORP (Subject) CIK: 0000884939 (see all company filings)

IRS No.: 222859704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-45417 | Film No.: 97535160
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 315 POST ROAD WEST WESTPORT CT 06880
Business Address C/O OXFORD PARTNERS 315 POST ROAD WEST WESTPORT CT 06880 2033413300
OXFORD PARTNERS III LP (Filed by) CIK: 0001005954 (see all company filings)

IRS No.: 061125614 | State of Incorp.: DE | Fiscal Year End: 1231